These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32382154)

  • 41. Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China.
    Pan A; Liu L; Wang C; Guo H; Hao X; Wang Q; Huang J; He N; Yu H; Lin X; Wei S; Wu T
    JAMA; 2020 May; 323(19):1915-1923. PubMed ID: 32275295
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is Gradual and Controlled Approach to Herd Protection a Valid Strategy to Curb the COVID-19 Pandemic?
    Laxminarayan R; John TJ
    Indian Pediatr; 2020 Jun; 57(6):505-507. PubMed ID: 32376793
    [No Abstract]   [Full Text] [Related]  

  • 43. A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2.
    Britton T; Ball F; Trapman P
    Science; 2020 Aug; 369(6505):846-849. PubMed ID: 32576668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Piecewise-constant optimal control strategies for controlling the outbreak of COVID-19 in the Irish population.
    Náraigh LÓ; Byrne Á
    Math Biosci; 2020 Dec; 330():108496. PubMed ID: 33075364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. COVID-19 in Africa: Dampening the storm?
    Mbow M; Lell B; Jochems SP; Cisse B; Mboup S; Dewals BG; Jaye A; Dieye A; Yazdanbakhsh M
    Science; 2020 Aug; 369(6504):624-626. PubMed ID: 32764055
    [No Abstract]   [Full Text] [Related]  

  • 46. A guide to R - the pandemic's misunderstood metric.
    Adam D
    Nature; 2020 Jul; 583(7816):346-348. PubMed ID: 32620883
    [No Abstract]   [Full Text] [Related]  

  • 47. Modeling between-population variation in COVID-19 dynamics in Hubei, Lombardy, and New York City.
    Wilder B; Charpignon M; Killian JA; Ou HC; Mate A; Jabbari S; Perrault A; Desai AN; Tambe M; Majumder MS
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25904-25910. PubMed ID: 32973089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. General Model for COVID-19 Spreading With Consideration of Intercity Migration, Insufficient Testing, and Active Intervention: Modeling Study of Pandemic Progression in Japan and the United States.
    Zhan C; Tse CK; Lai Z; Chen X; Mo M
    JMIR Public Health Surveill; 2020 Jul; 6(3):e18880. PubMed ID: 32589145
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Herd immunity - estimating the level required to halt the COVID-19 epidemics in affected countries.
    Kwok KO; Lai F; Wei WI; Wong SYS; Tang JWT
    J Infect; 2020 Jun; 80(6):e32-e33. PubMed ID: 32209383
    [No Abstract]   [Full Text] [Related]  

  • 50. COVID-19 in South Korea.
    Choi JY
    Postgrad Med J; 2020 Jul; 96(1137):399-402. PubMed ID: 32366457
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COVID-19 Mitigation Behaviors by Age Group - United States, April-June 2020.
    Hutchins HJ; Wolff B; Leeb R; Ko JY; Odom E; Willey J; Friedman A; Bitsko RH
    MMWR Morb Mortal Wkly Rep; 2020 Oct; 69(43):1584-1590. PubMed ID: 33119562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Controlling the Spread of COVID-19: Optimal Control Analysis.
    Madubueze CE; Dachollom S; Onwubuya IO
    Comput Math Methods Med; 2020; 2020():6862516. PubMed ID: 32963585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparing for the Next Wave of COVID-19: Resilience in the Face of a Spreading Pandemic.
    Steiner G; Zenk L; Schernhammer E
    Int J Environ Res Public Health; 2020 Jun; 17(11):. PubMed ID: 32521811
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Passport to freedom? Immunity passports for COVID-19.
    Brown RCH; Savulescu J; Williams B; Wilkinson D
    J Med Ethics; 2020 Oct; 46(10):652-659. PubMed ID: 32817362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Timing of Community Mitigation and Changes in Reported COVID-19 and Community Mobility - Four U.S. Metropolitan Areas, February 26-April 1, 2020.
    Lasry A; Kidder D; Hast M; Poovey J; Sunshine G; Winglee K; Zviedrite N; Ahmed F; Ethier KA; ; ; ; ; ; ; ;
    MMWR Morb Mortal Wkly Rep; 2020 Apr; 69(15):451-457. PubMed ID: 32298245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modeling, state estimation, and optimal control for the US COVID-19 outbreak.
    Tsay C; Lejarza F; Stadtherr MA; Baldea M
    Sci Rep; 2020 Jul; 10(1):10711. PubMed ID: 32612204
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immune Correlates of COVID-19 Control.
    Poonia B; Kottilil S
    Front Immunol; 2020; 11():569611. PubMed ID: 33133083
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Modeling return of the epidemic: Impact of population structure, asymptomatic infection, case importation and personal contacts.
    Yu X
    Travel Med Infect Dis; 2020; 37():101858. PubMed ID: 32860959
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mathematic modeling of COVID-19 in the United States.
    Tang Y; Wang S
    Emerg Microbes Infect; 2020 Dec; 9(1):827-829. PubMed ID: 32338150
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Projected effects of nonpharmaceutical public health interventions to prevent resurgence of SARS-CoV-2 transmission in Canada.
    Ng V; Fazil A; Waddell LA; Bancej C; Turgeon P; Otten A; Atchessi N; Ogden NH
    CMAJ; 2020 Sep; 192(37):E1053-E1064. PubMed ID: 32778573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.